1. Home
  2. SAMG vs ELTX Comparison

SAMG vs ELTX Comparison

Compare SAMG & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAMG
  • ELTX
  • Stock Information
  • Founded
  • SAMG 2002
  • ELTX 2011
  • Country
  • SAMG United States
  • ELTX United States
  • Employees
  • SAMG N/A
  • ELTX N/A
  • Industry
  • SAMG Investment Managers
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SAMG Finance
  • ELTX Health Care
  • Exchange
  • SAMG Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • SAMG 149.2M
  • ELTX 121.7M
  • IPO Year
  • SAMG 2013
  • ELTX N/A
  • Fundamental
  • Price
  • SAMG $14.78
  • ELTX $4.76
  • Analyst Decision
  • SAMG
  • ELTX Strong Buy
  • Analyst Count
  • SAMG 0
  • ELTX 2
  • Target Price
  • SAMG N/A
  • ELTX $9.50
  • AVG Volume (30 Days)
  • SAMG 72.9K
  • ELTX 45.3K
  • Earning Date
  • SAMG 05-01-2025
  • ELTX 05-14-2025
  • Dividend Yield
  • SAMG 5.40%
  • ELTX N/A
  • EPS Growth
  • SAMG 4.17
  • ELTX N/A
  • EPS
  • SAMG 1.00
  • ELTX N/A
  • Revenue
  • SAMG $123,651,000.00
  • ELTX N/A
  • Revenue This Year
  • SAMG $9.70
  • ELTX N/A
  • Revenue Next Year
  • SAMG $7.28
  • ELTX N/A
  • P/E Ratio
  • SAMG $14.78
  • ELTX N/A
  • Revenue Growth
  • SAMG 5.32
  • ELTX N/A
  • 52 Week Low
  • SAMG $14.12
  • ELTX $3.34
  • 52 Week High
  • SAMG $19.20
  • ELTX $11.45
  • Technical
  • Relative Strength Index (RSI)
  • SAMG 32.30
  • ELTX 30.36
  • Support Level
  • SAMG $14.26
  • ELTX $4.61
  • Resistance Level
  • SAMG $15.92
  • ELTX $5.11
  • Average True Range (ATR)
  • SAMG 0.70
  • ELTX 0.69
  • MACD
  • SAMG -0.01
  • ELTX -0.07
  • Stochastic Oscillator
  • SAMG 22.13
  • ELTX 5.56

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: